Vanprox®
Cefpodoxime Proxetil
3rd Generation Cephalosporin (Cephalosporin Antibiotic)
Indication:
Lower respiratory tract infections, Upper respiratory tract infections, Urinary tract infections including gonorrhea, cystitis, Skin & soft tissue infections, Gynecological infections, Acute otitis media, Childhood infections.
Dosage & Administration:
Adults (Including age 13 years & older):
Type of infection | Total daily dose | Dose Frequency | Duration |
Acute community-acquired pneumonia | 400 mg | 200 mg 12 hourly | 14 days |
Acute bacterial exacerbation of chronic bronchitis | 400 mg | 200 mg 12 hourly | 10 days |
Uncomplicated gonorrhea (men/women) | 200 mg | Single dose | |
Rectal gonococcal infection in women | 200 mg | Single dose | |
Skin and soft tissue infections | 800 mg | 400 mg 12 hourly | 7 to 14 days |
Pharyngitis and/or tonsillitis | 200 mg | 100 mg 12 hourly | 5 to 10 days |
Uncomplicated urinary tract infection | 200 mg | 100 mg 12 hourly | 7 days |
Acute maxillary sinusitis | 400 mg | 200 mg 12 hourly | 10 days |
Child:
15 days-6 months: 4 mg/kg every 12 hours,
6 months-2 years: 40 mg every 12 hours,
3-8 years: 80 mg every 12 hours,
Over 9 years: 100 mg every 12 hours.
Preparation:
Vanprox® suspension: Bottle containing dry powder to reconstitute 50 ml suspension.
Vanprox® Paediatric Drops: Bottle containing powder to reconstitute 15 ml suspension.